How does Learningrx's Item 11 obligation to approve a physical location relate to the franchisee's responsibility for site selection in Item 9?

According to the 2025 Learningrx Franchise Disclosure Document, Item 11 outlines Learningrx's obligation to approve the franchisee's site selection, while Item 9 specifies that site selection is the franchisee's responsibility. Specifically, Learningrx will designate the territory in writing and must approve the physical location selected by the franchisee if it meets Learningrx's standards and specifications. Learningrx also provides limited advice about selecting and analyzing a site, considering factors such as population density, income levels, general location guidelines, and proximity to other Learningrx centers. The franchisee is responsible for locating a site for the business and negotiating the lease.

If Learningrx and the franchisee cannot agree on the site selection, the franchisee must select two alternate sites, which Learningrx will then evaluate. Learningrx must approve or disapprove the franchisee's proposed site within 30 days of receiving written notice. Failure to obtain written approval within this timeframe is deemed a disapproval. However, Learningrx's assistance does not constitute a warranty regarding the property or lease.

This process highlights a shared responsibility: the franchisee bears the primary responsibility for finding a suitable location, but Learningrx retains the right to approve the site to ensure it aligns with their brand standards and strategic objectives. This is a common arrangement in franchising, where the franchisor seeks to maintain consistency and protect brand image, while the franchisee benefits from local knowledge and initiative. The franchisee bears the risk of site selection, as the FDD states that establishing a site prior to Learningrx's approval is the sole risk and responsibility of the Area Developer and does not obligate Learningrx to approve it.